The Tema Heart & Health ETF (HRTS) seeks to invest in companies that potentially stand to benefit from further advances in biotechnology and healthcare, specifically companies involved in cardiology, metabolic diseases and weight loss therapies.
Tema Cardiovascular and Metabolic ETF · Issued by Tema
| LLY | Eli Lilly and Co | 11.22% |
| TMO | Thermo Fisher Scientific Inc | 5.14% |
| UNH | UnitedHealth Group Inc | 5.06% |
| NOVO-B.CO | Novo Nordisk AS Class B | 5.05% |
| MRK | Merck & Co Inc | 4.31% |
| JNJ | Johnson & Johnson | 3.91% |
| RHHBY | Roche Holding AG ADR | 3.85% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 3.70% |
| CYTK | Cytokinetics Inc | 3.28% |
| ABT | Abbott Laboratories | 3.14% |
No recent news for HRTS. The ingest cron pulls every 15 minutes during market hours.